OMM Scientific

OMM Scientific is a biotechnology company focused on developing novel small molecule therapeutics that target mitochondrial dysfunction and oxidative stress. The company's proprietary platform identifies compounds that can modulate cellular energy production and reduce harmful reactive oxygen species. Their primary therapeutic focus includes neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as rare mitochondrial disorders. OMM Scientific aims to address the underlying metabolic imbalances that drive chronic disease progression. The company leverages its expertise in mitochondrial biology to create disease-modifying treatments for conditions with high unmet medical needs.